Company News

LEO Pharma and Bayer Complete Rx Derm Transfer

Expands reach in acne, fungal skin infections and rosacea and to international markets.

Author Image

By: Christine Esposito

Editor-in-Chief

LEO Pharma and Bayer have closed the transfer of Bayer’s global prescription dermatology business to the Denmark-based dermatology company. The companies first announced the proposed transaction on July 31, 2018 and completed the first step of the acquisition with the closing in the US on September 2018. Today’s second and final closing covers all other countries. “Today is a historic day for LEO Pharma,” said Gitte Aabo, president and CEO of LEO Pharma. “With the strong prescription dermatol...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters